Приказ основних података о документу

dc.creatorIlkić, Jovana
dc.creatorObradović, Dragiša
dc.creatorMilošević-Georgiev, Andrijana
dc.creatorMarinković, Valentina
dc.creatorTadić, Ivana
dc.date.accessioned2023-01-31T15:29:05Z
dc.date.available2023-01-31T15:29:05Z
dc.date.issued2023
dc.identifier.issn0019-5464
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4401
dc.description.abstractThis systematic literature review aimed to provide an overview of the characteristics and methods used in studies applying the Disability-Adjusted Life Years (DALY) concept for infectious diseases within European Union (EU)/European Economic Area (EEA)/European Free Trade Association (EFTA) countries and the United Kingdom. Electronic databases and grey literature were searched for articles reporting the assessment of DALY and its components. We considered studies in which researchers performed DALY calculations using primary epidemiological data input sources. We screened 3,053 studies of which 2,948 were excluded and 105 studies met our inclusion criteria. Of these studies, 22 were multi-country and 83 were single-country studies, of which 46 were from the Netherlands. Food- and water-borne diseases were the most frequently studied infectious diseases. Between 2015 and 2022, the number of burden of infectious disease studies was 1.6 times higher compared to that published between 2000 and 2014. Almost all studies (97%) estimated DALYs based on the incidence- and pathogen-based approach and without social weighting functions; however, there was less methodological consensus with regards to the disability weights and life tables that were applied. The number of burden of infectious disease studies undertaken across Europe has increased over time. Development and use of guidelines will promote performing burden of infectious disease studies and facilitate comparability of the results.
dc.publisherAssociation of Pharmaceutical Teachers of India
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceIndian Journal of Pharmaceutical Education and Research
dc.subjectPharmaceutical care
dc.subjectPharmacy services
dc.subjectPublic health
dc.subjectTelehealth
dc.subjectTelemedicine
dc.titleImplementation of Telepharmacy Services in Community Pharmacy – Pharmacists’ Perspective in Republic of Serbia
dc.typearticle
dc.rights.licenseBY
dc.citation.volume57
dc.citation.issue1
dc.citation.spage286
dc.citation.epage294
dc.citation.rankM23~
dc.identifier.wos000936542200036
dc.identifier.doi10.5530/001954641895
dc.identifier.scopus2-s2.0-85146370639
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/11729/Implementation_of_Telepharmacy_pub_2023.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу